Quantum Total Assets from 2010 to 2025
| QNTM Stock | 4.89 0.38 8.43% |
Total Assets | First Reported 2010-12-31 | Previous Quarter 15.7 M | Current Value 14.9 M | Quarterly Volatility 12.2 M |
Check Quantum BioPharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quantum BioPharma's main balance sheet or income statement drivers, such as Cost Of Revenue of 1.6 M, Net Interest Income of 949.2 K or Interest Income of 949.5 K, as well as many indicators such as . Quantum financial statements analysis is a perfect complement when working with Quantum BioPharma Valuation or Volatility modules.
Quantum | Total Assets |
Latest Quantum BioPharma's Total Assets Growth Pattern
Below is the plot of the Total Assets of Quantum BioPharma over the last few years. Total assets refers to the total amount of Quantum BioPharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Quantum BioPharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Quantum BioPharma's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quantum BioPharma's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 17.47 M | 10 Years Trend |
|
Total Assets |
| Timeline |
Quantum Total Assets Regression Statistics
| Arithmetic Mean | 38,197,261 | |
| Geometric Mean | 35,732,404 | |
| Coefficient Of Variation | 32.03 | |
| Mean Deviation | 8,306,079 | |
| Median | 41,967,205 | |
| Standard Deviation | 12,233,564 | |
| Sample Variance | 149.7T | |
| Range | 48M | |
| R-Value | (0.52) | |
| Mean Square Error | 117.7T | |
| R-Squared | 0.27 | |
| Significance | 0.04 | |
| Slope | (1,324,949) | |
| Total Sum of Squares | 2244.9T |
Quantum Total Assets History
About Quantum BioPharma Financial Statements
Quantum BioPharma investors utilize fundamental indicators, such as Total Assets, to predict how Quantum Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Assets | 15.7 M | 14.9 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Quantum BioPharma Correlation against competitors. To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quantum BioPharma. If investors know Quantum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quantum BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quantum BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quantum BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quantum BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.